Skip to content
10-Q

Quarterly Report

HOOKIPA PHARMA INC.

0001558370-25-007871

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2025 · Mar 31, 2025 12.54M sh
Shares Diluted restated Q1 2025 · Mar 31, 2024 12.6M sh
Capex Q1 2025 · Mar 31, 2025 $20K
Capex Q1 2025 · Mar 31, 2024 $116K
Operating Cash Flow Q1 2025 · Mar 31, 2025 $52K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$24.16M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $40.28M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $39.68M
Stockholders Equity Q1 2025 · Mar 31, 2025 $34.08M
Stockholders Equity Q1 2025 · Dec 31, 2024 $51.21M
Stockholders Equity Q1 2025 · Mar 31, 2024 $104.52M
Stockholders Equity Q1 2025 · Dec 31, 2023 $89.86M
Current Liabilities Q1 2025 · Mar 31, 2025 $16.64M
Current Liabilities Q1 2025 · Dec 31, 2024 $24.65M
Total Liabilities Q1 2025 · Mar 31, 2025 $27.18M
Total Liabilities Q1 2025 · Dec 31, 2024 $31.33M
Current Assets Q1 2025 · Mar 31, 2025 $60.09M
Current Assets Q1 2025 · Dec 31, 2024 $80.67M
Total Assets Q1 2025 · Mar 31, 2025 $61.26M
Total Assets Q1 2025 · Dec 31, 2024 $82.55M
Eps Diluted Q1 2025 · Mar 31, 2025 −$1.23
Eps Diluted restated Q1 2025 · Mar 31, 2024 $1.14
Eps Basic Q1 2025 · Mar 31, 2025 −$1.23
Eps Basic restated Q1 2025 · Mar 31, 2024 $1.15
Sga Expense Q1 2025 · Mar 31, 2025 $6.89M
Sga Expense Q1 2025 · Mar 31, 2024 $4.06M
Rd Expense Q1 2025 · Mar 31, 2025 $12.86M
Rd Expense Q1 2025 · Mar 31, 2024 $20.17M
Net Income Q1 2025 · Mar 31, 2025 −$15.43M
Net Income Q1 2025 · Dec 31, 2024 −$43.5M
Net Income Q1 2025 · Mar 31, 2024 $14.38M
Operating Income Q1 2025 · Mar 31, 2025 −$17.87M
Operating Income Q1 2025 · Mar 31, 2024 $11.11M
Revenue Q1 2025 · Mar 31, 2025 $2M
Revenue Q1 2025 · Mar 31, 2024 $36.6M